HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McNeil OTC Recalls Slice $900M From J&J's 2010 Sales

This article was originally published in The Tan Sheet

Executive Summary

Recalled OTC drugs took a $900 million bite out of Johnson & Johnson's fiscal 2010 sales, including $300 million in the fourth quarter, contributing to what the company and analysts labeled disappointing earnings.

You may also be interested in...

J&J Plans To Upgrade Recalled OTCs for Relaunch

Johnson & Johnson plans to return recalled OTC drugs to the market with innovations designed to strengthen consumer trust, VP of Finance and CFO Dominic Caruso said during a presentation at the Deutsche Bank Securities Health Care Conference.

Trends That Affected OTC Sales In 2010

The global OTC industry fell back in line with the world gross domestic product in 2010, after significantly outpacing it in 2009. The industry grew 4% in 2010, 1.2 percentage points behind the previous year and 0.2 percentage points below the broader GDP, according to Nicholas Hall, CEO of Nicholas Hall & Company.

Homeopathy Gains From J&J Recalls As Consumers, Retailers Seek Alternatives

Johnson & Johnson's OTC drug recalls are driving interest in homeopathic remedies and other alternative health products, experts and stakeholders say.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts